Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Total Liabilities (2016 - 2017)

Historic Total Liabilities for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to $2.4 million.

  • Eledon Pharmaceuticals' Total Liabilities fell 6287.13% to $2.4 million in Q3 2017 from the same period last year, while for Sep 2017 it was $2.4 million, marking a year-over-year decrease of 6287.13%. This contributed to the annual value of $3.9 million for FY2016, which is 3763.2% down from last year.
  • Latest data reveals that Eledon Pharmaceuticals reported Total Liabilities of $2.4 million as of Q3 2017, which was down 6287.13% from $3.4 million recorded in Q2 2017.
  • Eledon Pharmaceuticals' 5-year Total Liabilities high stood at $8.0 million for Q2 2016, and its period low was $2.2 million during Q4 2013.
  • Moreover, its 5-year median value for Total Liabilities was $5.0 million (2014), whereas its average is $4.8 million.
  • Per our database at Business Quant, Eledon Pharmaceuticals' Total Liabilities skyrocketed by 9207.79% in 2014 and then tumbled by 6287.13% in 2017.
  • Over the past 5 years, Eledon Pharmaceuticals' Total Liabilities (Quarter) stood at $2.2 million in 2013, then skyrocketed by 92.08% to $4.2 million in 2014, then surged by 47.3% to $6.2 million in 2015, then tumbled by 37.63% to $3.9 million in 2016, then tumbled by 38.43% to $2.4 million in 2017.
  • Its Total Liabilities was $2.4 million in Q3 2017, compared to $3.4 million in Q2 2017 and $2.5 million in Q1 2017.